Form D · Venture Capital Fund
FCA Health Innovations III AI, LP
Nashville, TN · CIK 0002133480
Offering snapshot reported May 15, 2026 · SEC filing
- Reported sold
- $3.1M Offering amount: $175M
- Investors reported
- 22 Form D · investor count
- Minimum accepted
- $100K Reported outside-investor minimum
- First sale
- Apr 30, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 15, 2026 | Initial | $3,100,000 | No comparison | 22 | SEC filing |
Offering details
- Securities
- Equity, Pooled investment fund
- Exemptions
- 06b, 3C, 3C.1
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-584297
Source: Form D, filed May 15, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
The linked fund shows its most recently reported ADV details.
Matched by reported Form D file number
FCA HEALTH INNOVATIONS III AI LP
Investment adviser: FCA MANAGEMENT GROUP, LLC
- Gross asset value
- $3.1M
- Beneficial owners
- 22
- ADV minimum commitment
- $250K
Reported in Form ADV on Jun 30, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.
Service providers
Provider details
- Annual audit
- No
- Prime brokers
- No
- Custodians
- Yes
- Administrator other than the adviser
- Yes
- External marketing
- No
PINNACLE FINANCIAL PARTNERS INC
LEI 54930098EZ8JMSAZGS24
Filing source
Form ADV 2116001 · Jun 30, 2026 · Schedule D 7.B.(1), fund 805-1111017904
Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Andrew J. Bouldin | Executive |
| . Fca Health Innovations Iii Gp, Llc | Executive |
| . Fca Health Innovations Iii Slp, Llc | Executive |
| Charles W. Johnson | Executive |
| Whitney H. Kalb | Executive |
| Matthew A. King | Executive |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:Nashville, TN, 37215